HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Complete remission of recurrent ovarian dysgerminoma obtained by combined chemotherapy with cisplatin, adriamycin and cyclophosphamide].

Abstract
Based on the clinical course of ovarian dysgerminoma with multiple metastatic foci in the lung recurring at 7 years and a half after initial therapy, various problems of diagnosis, treatment, and administration of this tumor were discussed. As to the multiple recurrent foci, complete remission was obtained by 3 courses of combined chemotherapy with cisplatin, adriamycin and cyclophosphamide. Generally speaking, this type of tumor is remarkably sensitive to various kinds of oncostatics, and chemotherapy involving the above chemotherapeutic agents is worth trying in selective cases of advanced or recurrent cases.
AuthorsH Yokota, M Saito, H Tsunoda, K Kawagoe
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 12 Issue 1 Pg. 151-4 (Jan 1985) ISSN: 0385-0684 [Print] Japan
PMID4038447 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cisplatin (administration & dosage)
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Drug Administration Schedule
  • Dysgerminoma (drug therapy, secondary)
  • Female
  • Humans
  • Lung Neoplasms (drug therapy, secondary)
  • Ovarian Neoplasms

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: